In a report published today, Piper Jeffray maintains its Athena Health ATHN Overweight rating and its $46 PT.
In the report, Piper Jaffray states, "Our meeting with ATHN management offered some new updates on the Enterprise strategy, athenaclinicals, and the sales strategy. After a challenging 2010, CEO Jonathan Bush is "recharged" and aiming to gain market share in the Enterprise setting. A new President of the Enterprise Group, a focused strategy, and a healthy pipeline should bode well for deal flow and doc-adds in 2011. Incremental improvements in athenaclinicals workflow should help margins, and incremental investments in Sales & Marketing will be put to good use."
Athena Health shares are trading at $41.33, -0.83% from Thursday's market close.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in